ராஜீவ் கோசில News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ராஜீவ் கோசில. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ராஜீவ் கோசில Today - Breaking & Trending Today

Enteris BioPharma Completes Expansion of Manufacturing Facility and Announces Launch of CDMO Business Segment


Enteris BioPharma Completes Expansion of Manufacturing Facility and Announces Launch of CDMO Business Segment
CDMO Business Driven by Custom Solutions from Bench to Market for the Development and Manufacture of Difficult to Formulate Drugs and Highly Potent Compounds
News provided by
Share this article
Share this article
BOONTON, N.J., May 3, 2021 /PRNewswire/  Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), today announced the expansion of its Boonton, NJ manufacturing facility and the launch of its CDMO business segment, providing custom solutions for the formulation, development and manufacturing of solid oral doses for difficult to formulate BCS III and IV compounds, including peptides and highly potent compounds. Enteris now provides bench to market services, including the development, manufacture, ....

Enteris Biopharma , Paul Shields , Rajiv Khosla , Enteris Biopharma Inc , Holdings Corporation Nasdaq , Chief Executive Officer , Chief Operating Officer , பால் கவசங்கள் , ராஜீவ் கோசில , ஹோல்டிங்ஸ் நிறுவனம் நாஸ்டாக் , தலைமை நிர்வாகி அதிகாரி , தலைமை இயங்குகிறது அதிகாரி ,

SWK Holdings Corporation Announces Financial Results for Fourth Quarter and Full-Year 2020


Corporate Highlights
Closed four transactions in 2020 deploying $34.8 million; additional $8.1 million deployed to existing borrowers
Income producing assets as of December 31, 2020 reached an all-time high of $206.0 million, accompanied by strong credit trends
Closed a $9.0 million transaction in March 2021, deploying $7.1 million
Received two milestone payments from Cara Therapeutics totaling $5.0 million, with SWK retaining $3.0 million and the other $2.0 million being remitted to Enteris  prior owner. 
Specialty Finance Segment Highlights:
For the fourth quarter of 2020, finance portfolio realized yield was 16.6%, compared to 20.4% for the fourth quarter of 2019
For the fourth quarter of 2020, finance portfolio effective yield was 13.8%, a 60 bps increase compared with 13.2% in the fourth quarter of 2019 ....

United States , Enteris Biopharma , Rajiv Khosla , Flowonix Medical Inc , Alimera Sciences Inc , Holdings Corporation , Sincerus Pharmaceuticals Inc , Eyepoint Pharmaceuticals Inc , Holdings Corporation Nasdaq , Cara Therapeutics , Finance Segment Highlights , Winston Black , Sincerus Pharmaceuticals , Eyepoint Pharmaceuticals , Alimera Sciences , Trio Healthcare , Flowonix Medical , Year Ended , Investors Events , Swk Holdings Corporation , ஒன்றுபட்டது மாநிலங்களில் , ராஜீவ் கோசில , ஹோல்டிங்ஸ் நிறுவனம் , ஹோல்டிங்ஸ் நிறுவனம் நாஸ்டாக் , காரா சிகிச்சை , நிதி பிரிவு சிறப்பம்சங்கள் ,